Lenshil 18mg Capsule

Lenshil 18mg Capsule contains the active ingredient Lenvatinib, a tyrosine kinase inhibitor. It is indicated for progressive or advanced thyroid cancer when radioactive iodine therapy has proven ineffective. It is also used to treat previously untreated hepatocellular carcinoma in patients ineligible for surgical intervention. Anaplastic thyroid carcinoma, an advanced form of thyroid cancer, typically occurs in patients aged 60 years and above. It presents with an enlarged and hardened thyroid gland and hoarseness of voice resulting from paralysis of the laryngeal nerve. Hepatocellular carcinoma develops secondary to pre-existing liver conditions such as cirrhosis or chronic hepatitis B infection. Patients with a known hypersensitivity to Lenvatinib or any component of Lenshil 18mg Capsule should not use this medication. Patients should notify their dentist or oral surgeon of Lenshil 18mg Capsule use, as it may impair wound healing and increase the risk of bleeding.

Lenshil 18mg Capsule is indicated to treat the following conditions: Certain types of advanced thyroid cancer Advanced Liver cancer Certain types of kidney cancer Endometrial cancer

Lenshil 18mg Capsule blocks the enzyme receptor tyrosine kinases (RTKs). RTKs develop new blood vessels that supply oxygen and nutrients to the cells and help them grow. This medicine inhibits the receptors that facilitate the growth of blood vessels in tumor cells. RTKs are present in high concentrations in cancer cells, and administration of this medicine slows down the rate of cancer cells’ growth and multiplication.

Lenshil 18mg Capsule is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up the second dose.

Like all medications, Lenshil 18mg Capsule can cause side effects, although not everyone who takes it will experience them. Serious: Liver toxicity or liver failure Heart problems, such as heart attack Hemorrhage (bleeding) Blood clots Poor wound healing Kidney failure Hypothyroidism Skin reactions (rash or blisters) Common: Fatigue Loss of appetite Weight loss Nausea and vomiting Diarrhea Stomach pain or discomfort Hypertension (high blood pressure) Headache Joint pain or muscle pain Changes in taste

If you are receiving close communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Patients should use effective contraception while taking Lenshil 18mg Capsule and for at least two weeks after stopping treatment. Patients should avoid eating grapefruits as they affect the absorption of this drug. Patients should use sunscreen and wear protective clothing while outdoors to reduce the risk of sunburn or skin damage. You should avoid strenuous activities or exercise until you know how this medication is affecting you. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. By being informed and engaged in your treatment, you can help ensure the best possible outcomes and manage any potential risks or complications associated.